NCT00505895 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- The end of active treatment was the day of the drug administration of Rituximab on Day+16. Study participation was from baseline to 100 days after transplantation. Overall study period was March 2002 to May 2013.
- Other-event reporting threshold
- 0%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Fludarabine + Melphalan + Stem Cell Infusion | 23 / 27 | 8 / 27 | Not reported / Not reported |
| Fludarabine + Lower-Dose Melphalan + Stem Cell Infusion | 16 / 23 | 10 / 23 | Not reported / Not reported |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 27
- num Events
- 23
- group Id
- EG001
- num Affected
- 16
- num At Risk
- 23
- num Events
- 16
- term
- Death
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 27
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 27
- num Events
- 5
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 23
- num Events
- 14
- term
- Infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 27
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Pneumonitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- term
- Seizures
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 27
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- term
- Total Bilirubin Level Change
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 27
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Secondary graft failure
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 27
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Rash
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 27
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Altered mental status
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 27
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Elevated creatinine
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- term
- Pulmonary hemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- term
- Elevated ALT
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 27
- num Events
- 3
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 23
- num Events
- 3
- term
- Fever
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 23
- num Events
- 3
- term
- Volume overload
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Hypertension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 27
- num Events
- 5
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 23
- num Events
- 6
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 27
- num Events
- 3
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 23
- num Events
- 5
- term
- Dysphagia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 27
- num Events
- 8
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 23
- num Events
- 11
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 27
- num Events
- 3
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 23
- num Events
- 3
- term
- Rash
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Dizziness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Hematuria
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Elevated Creatinine
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 23
- num Events
- 2
- term
- Conjunctivitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 27
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 23
- num Events
- 3
- term
- Infection
Complete source fields
- event Groups
- description
- Fludarabine 30 mg/m\^2 intravenous (IV) daily over 30 minutes for 4 Days (Beginning Day -4). Melphalan 140 mg/m\^2 IV over 20 minutes on Day -1. Stem Cell Infusion on Day 0. Rituximab 375 mg/m\^2 IV infused starting on day -5.
- id
- EG000
- other Num Affected
- 8
- other Num At Risk
- 27
- serious Num Affected
- 23
- serious Num At Risk
- 27
- title
- Fludarabine + Melphalan + Stem Cell Infusion
- description
- Fludarabine 30 mg/m\^2 IV daily over 30 minutes for 4 Days (Beginning Day -4). Lower-Dose Melphalan 100 mg/m\^2 IV over 20 minutes on Day -1. Stem Cell Infusion on Day 0. Rituximab 375 mg/m\^2 IV infused starting on day -5.
- id
- EG001
- other Num Affected
- 10
- other Num At Risk
- 23
- serious Num Affected
- 16
- serious Num At Risk
- 23
- title
- Fludarabine + Lower-Dose Melphalan + Stem Cell Infusion
- frequency Threshold
- 0
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 27
- num Events
- 3
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 23
- num Events
- 3
- term
- Fever
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 23
- num Events
- 3
- term
- Volume overload
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Hypertension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 27
- num Events
- 5
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 23
- num Events
- 6
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 27
- num Events
- 3
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 23
- num Events
- 5
- term
- Dysphagia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 27
- num Events
- 8
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 23
- num Events
- 11
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 27
- num Events
- 3
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 23
- num Events
- 3
- term
- Rash
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Dizziness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Hematuria
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Elevated Creatinine
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 23
- num Events
- 2
- term
- Conjunctivitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 27
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 23
- num Events
- 3
- term
- Infection
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 27
- num Events
- 23
- group Id
- EG001
- num Affected
- 16
- num At Risk
- 23
- num Events
- 16
- term
- Death
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 27
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 27
- num Events
- 5
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 23
- num Events
- 14
- term
- Infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 27
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Pneumonitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- term
- Seizures
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 27
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- term
- Total Bilirubin Level Change
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 27
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Secondary graft failure
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 27
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Rash
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 27
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Altered mental status
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 27
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- term
- Elevated creatinine
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- term
- Pulmonary hemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- CTCAE (3.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 27
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- term
- Elevated ALT
- time Frame
- The end of active treatment was the day of the drug administration of Rituximab on Day+16. Study participation was from baseline to 100 days after transplantation. Overall study period was March 2002 to May 2013.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle